Gilead Sciences Inc Stock
Price
Target price
€62.93
€62.93
0.110%
0.07
0.110%
€90.31
21:09 / Tradegate
WKN: 885823 / Symbol: GILD / Name: Gilead Sciences / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Gilead Sciences Inc Stock
Gilead Sciences Inc gained 0.110% compared to yesterday.
We see a rather positive sentiment for Gilead Sciences Inc with 9 Buy predictions and 1 Sell predictions.
With a target price of 90 € there is a positive potential of 43.02% for Gilead Sciences Inc compared to the current price of 62.93 €.
So far the community has only identified positive things for Gilead Sciences Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Gilead Sciences Inc in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gilead Sciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | 0.110% | -1.427% | -6.514% | -20.228% | -14.032% | 15.023% | 12.110% |
| Exact Sciences | 3.250% | -4.684% | 2.180% | -4.498% | -14.490% | -45.816% | -30.651% |
| Incyte Corp. | -1.520% | -3.063% | -7.549% | -28.197% | -14.099% | -30.451% | -25.531% |
| Regeneron Pharmaceuticals Inc. | 0.730% | -0.047% | -5.639% | 15.992% | 5.956% | 107.184% | 183.177% |
Comments
Gilead Sciences, Inc. (NASDAQ: GILD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences, Inc. (NASDAQ: GILD) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $105.00 price target on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target lowered by analysts at Mizuho from $101.00 to $90.00. They now have a "buy" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
